Pavel Mirovsky
2013
In 2013, Pavel Mirovsky earned a total compensation of $823.9K as President and General Manager, Europe at Valeant Pharmaceuticals International, a 51% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $377,275 |
|---|---|
| Salary | $425,003 |
| Other | $21,625 |
| Total | $823,903 |
Mirovsky received $425K in salary, accounting for 52% of the total pay in 2013.
Mirovsky also received $377.3K in non-equity incentive plan and $21.6K in other compensation.
Rankings
In 2013, Pavel Mirovsky's compensation ranked 7,463rd out of 12,286 executives tracked by ExecPay. In other words, Mirovsky earned more than 39.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,463 out of 12,286 | 39th |
Division Manufacturing | 2,685 out of 4,614 | 42nd |
Major group Chemicals And Allied Products | 840 out of 1,466 | 43rd |
Industry group Drugs | 630 out of 1,160 | 46th |
Industry Pharmaceutical Preparations | 495 out of 890 | 44th |
Source: SEC filing on April 9, 2015.
Mirovsky's colleagues
We found seven more compensation records of executives who worked with Pavel Mirovsky at Valeant Pharmaceuticals International in 2013.
2013
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2013
Laizer Kornwasser
Valeant Pharmaceuticals International
Group Chairman
2013
Daniel Wechsler
Valeant Pharmaceuticals International
Group Chairman
2013
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2013
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2013
Debora Jorn
Valeant Pharmaceuticals International
Group Chairman
2013
Brian Stolz
Valeant Pharmaceuticals International